Biological Agent User Application Forms
As an institution receiving funding from the National Institutes of Health (NIH), WSU is subject to the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules.
Risk Group 2 (RG2) agents are associated with human disease for which preventative or therapeutic interventions are often available.
All research with RG2 agents requires review by the IBC. For a complete list, see Appendix B-II in the NIH Guidelines. Common examples of RG2 Agents include:
- Adeno Associated Virus (AAV)
- Adeno Associated Virus Serotype 2 (AAV2)
- Herpes virus
- Murine Stem Cell Virus (Retrovirus)
- Staph Aureus
- Streptococcus species
Please contact the WSU Biosafety Officer prior to initiating a new IBC protocol application on (313) 993 7597 or firstname.lastname@example.org
- Viruses (Mammalian - Native or Recombinant)
- Other Pathogenic / Infectious Agents (bacteria, fungi)
- NIH-exempt rDNA / Synthetic Nucleic Acid Molecules
- Select Agents (CDC / USDA) and Toxins
- Inactivated Biological Agents (Risk Group 3 and 4, Select Agents)
- Human Gene Transfer
- Human Materials (including human cell lines, tissue, blood, etc.)
All IBC applications and written standard operating procedures (SOPs) must be turned into the Biological Safety Officer two weeks before the scheduled IBC meeting.
- Animal Research Covered Under the NIH Guidelines - Table
- WSU Biosafety Manual - must be available in your lab
- IBC Frequently Asked Questions
- Laboratory Biosafety Resources - biosafety cabinets, training, disinfection, waste disposal, etc.
Questions? Contact Richard Pearson, Biosafety Officer at 313-577-1200 or email@example.com